Stocks and InvestingStocks and Investing
Fri, May 27, 2022
Thu, May 26, 2022
Wed, May 25, 2022
Tue, May 24, 2022

Chris Shibutani Maintained (TRDA) at Hold with Decreased Target to $10 on, May 24th, 2022


Published on 2024-10-27 21:16:37 - WOPRAI, Chris Shibutani
  Print publication without navigation


Chris Shibutani of Goldman Sachs, Maintained "Entrada Therapeutics, Inc." (TRDA) at Hold with Decreased Target from $22 to $10 on, May 24th, 2022.

Chris, nor any peers, have made any analyst calls on TRDA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30